ID   NUP42_HUMAN             Reviewed;         423 AA.
AC   O15504; A4D143; B4DP42; Q49AE7; Q9BS49;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   28-JUN-2023, entry version 171.
DE   RecName: Full=Nucleoporin NUP42 {ECO:0000305};
DE   AltName: Full=NLP-1;
DE   AltName: Full=NUP42 homolog;
DE   AltName: Full=Nucleoporin hCG1;
DE   AltName: Full=Nucleoporin-42 {ECO:0000312|HGNC:HGNC:17010};
DE   AltName: Full=Nucleoporin-like protein 2;
GN   Name=NUP42 {ECO:0000312|HGNC:HGNC:17010}; Synonyms=CG1, NUPL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9450185;
RA   Van Laer L., Van Camp G., van Zuylen D., Green E.D., Verstreken M.,
RA   Schatteman I., Van de Heyning P., Balemans W., Coucke P., Greinwald J.H.,
RA   Smith R.J.H., Huizing E., Willems P.;
RT   "Refined mapping of a gene for autosomal dominant progressive sensorineural
RT   hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene
RT   that is expressed in the cochlea.";
RL   Eur. J. Hum. Genet. 5:397-405(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Testis, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NXF1.
RX   PubMed=10228171; DOI=10.1093/emboj/18.9.2593;
RA   Katahira J., Straesser K., Podtelejnikov A., Mann M., Jung J.U., Hurt E.;
RT   "The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to
RT   human.";
RL   EMBO J. 18:2593-2609(1999).
RN   [7]
RP   FUNCTION.
RX   PubMed=10610322; DOI=10.1093/emboj/18.20.5761;
RA   Strahm Y., Fahrenkrog B., Zenklusen D., Rychner E., Kantor J., Rosbach M.,
RA   Stutz F.;
RT   "The RNA export factor Gle1p is located on the cytoplasmic fibrils of the
RT   NPC and physically interacts with the FG-nucleoporin Rip1p, the DEAD-box
RT   protein Rat8p/Dbp5p and a new protein Ymr255p.";
RL   EMBO J. 18:5761-5777(1999).
RN   [8]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH XPO1 AND HIV-1 VIRUS REV PROTEIN.
RX   PubMed=10358091; DOI=10.1074/jbc.274.24.17309;
RA   Farjot G., Sergeant A., Mikaelian I.;
RT   "A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear
RT   export signal and CRM-1.";
RL   J. Biol. Chem. 274:17309-17317(1999).
RN   [9]
RP   SUBCELLULAR LOCATION, INTERACTION WITH HIV-1 VIRUS VPR PROTEIN, AND
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=12228227; DOI=10.1074/jbc.m207439200;
RA   Le Rouzic E., Mousnier A., Rustum C., Stutz F., Hallberg E., Dargemont C.,
RA   Benichou S.;
RT   "Docking of HIV-1 Vpr to the nuclear envelope is mediated by the
RT   interaction with the nucleoporin hCG1.";
RL   J. Biol. Chem. 277:45091-45098(2002).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH GLE1.
RX   PubMed=16000379; DOI=10.1091/mbc.e04-11-0998;
RA   Kendirgi F., Rexer D.J., Alcazar-Roman A.R., Onishko H.M., Wente S.R.;
RT   "Interaction between the shuttling mRNA export factor Gle1 and the
RT   nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA.";
RL   Mol. Biol. Cell 16:4304-4315(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Required for the export of mRNAs containing poly(A) tails
CC       from the nucleus into the cytoplasm. {ECO:0000269|PubMed:10610322,
CC       ECO:0000269|PubMed:16000379}.
CC   -!- FUNCTION: (Microbial infection) In case of infection by HIV-1, it may
CC       participate in the docking of viral Vpr at the nuclear envelope.
CC       {ECO:0000269|PubMed:12228227}.
CC   -!- SUBUNIT: Probable component of the nuclear pore complex (NPC).
CC       Interacts with nuclear export protein NXF1 (PubMed:10228171). Interacts
CC       with GLE1. Able to form a heterotrimer with NUP155 and GLE1 in vitro
CC       (PubMed:16000379). Interacts with XPO1 (PubMed:10358091).
CC       {ECO:0000269|PubMed:10228171, ECO:0000269|PubMed:10358091,
CC       ECO:0000269|PubMed:16000379}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with the HIV-1 virus proteins
CC       Rev and Vpr. The interaction with HIV-1 Rev, a protein that mediates
CC       nuclear export of unspliced viral RNAs, suggests that its function may
CC       be bypassed by the HIV-1 virus. {ECO:0000269|PubMed:10358091,
CC       ECO:0000269|PubMed:12228227}.
CC   -!- INTERACTION:
CC       O15504-2; O76011: KRT34; NbExp=3; IntAct=EBI-14488689, EBI-1047093;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:12228227, ECO:0000269|PubMed:16000379}. Nucleus
CC       membrane {ECO:0000269|PubMed:12228227, ECO:0000269|PubMed:16000379};
CC       Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:12228227}. Note=Excluded from the nucleolus.
CC       {ECO:0000269|PubMed:10358091}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O15504-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15504-2; Sequence=VSP_016481, VSP_016482;
CC       Name=3;
CC         IsoId=O15504-3; Sequence=VSP_016480;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10358091}.
CC   -!- DOMAIN: The FG repeats are interaction sites for karyopherins
CC       (importins, exportins) and form probably an affinity gradient, guiding
CC       the transport proteins unidirectionally with their cargo through the
CC       NPC. {ECO:0000250}.
CC   -!- PTM: O-glycosylated. {ECO:0000269|PubMed:10358091}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U97198; AAC33794.1; -; mRNA.
DR   EMBL; BT007409; AAP36077.1; -; mRNA.
DR   EMBL; AK298183; BAG60454.1; -; mRNA.
DR   EMBL; CH236948; EAL24260.1; -; Genomic_DNA.
DR   EMBL; BC005327; AAH05327.1; -; mRNA.
DR   EMBL; BC039333; AAH39333.1; -; mRNA.
DR   CCDS; CCDS5379.1; -. [O15504-1]
DR   RefSeq; NP_031368.1; NM_007342.2. [O15504-1]
DR   PDB; 6B4F; X-ray; 2.81 A; C/D=381-423.
DR   PDB; 6B4I; X-ray; 3.62 A; C/D=381-423.
DR   PDB; 6B4J; X-ray; 3.40 A; C/D=376-422.
DR   PDBsum; 6B4F; -.
DR   PDBsum; 6B4I; -.
DR   PDBsum; 6B4J; -.
DR   AlphaFoldDB; O15504; -.
DR   SMR; O15504; -.
DR   BioGRID; 116278; 158.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   CORUM; O15504; -.
DR   IntAct; O15504; 25.
DR   MINT; O15504; -.
DR   STRING; 9606.ENSP00000258742; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   GlyCosmos; O15504; 3 sites, 1 glycan.
DR   GlyGen; O15504; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; O15504; -.
DR   PhosphoSitePlus; O15504; -.
DR   SwissPalm; O15504; -.
DR   BioMuta; NUPL2; -.
DR   EPD; O15504; -.
DR   jPOST; O15504; -.
DR   MassIVE; O15504; -.
DR   MaxQB; O15504; -.
DR   PaxDb; O15504; -.
DR   PeptideAtlas; O15504; -.
DR   ProteomicsDB; 48700; -. [O15504-1]
DR   ProteomicsDB; 48701; -. [O15504-2]
DR   ProteomicsDB; 48702; -. [O15504-3]
DR   Antibodypedia; 44074; 136 antibodies from 21 providers.
DR   DNASU; 11097; -.
DR   Ensembl; ENST00000258742.10; ENSP00000258742.5; ENSG00000136243.18. [O15504-1]
DR   Ensembl; ENST00000438012.5; ENSP00000415511.1; ENSG00000136243.18. [O15504-2]
DR   GeneID; 11097; -.
DR   KEGG; hsa:11097; -.
DR   MANE-Select; ENST00000258742.10; ENSP00000258742.5; NM_007342.3; NP_031368.1.
DR   UCSC; uc003svu.4; human. [O15504-1]
DR   AGR; HGNC:17010; -.
DR   CTD; 11097; -.
DR   DisGeNET; 11097; -.
DR   GeneCards; NUP42; -.
DR   HGNC; HGNC:17010; NUP42.
DR   HPA; ENSG00000136243; Low tissue specificity.
DR   MIM; 619998; gene.
DR   neXtProt; NX_O15504; -.
DR   OpenTargets; ENSG00000136243; -.
DR   PharmGKB; PA134990469; -.
DR   VEuPathDB; HostDB:ENSG00000136243; -.
DR   eggNOG; ENOG502R2TD; Eukaryota.
DR   GeneTree; ENSGT00390000000118; -.
DR   HOGENOM; CLU_048441_0_0_1; -.
DR   InParanoid; O15504; -.
DR   OMA; ELHLEYY; -.
DR   OrthoDB; 232322at2759; -.
DR   PhylomeDB; O15504; -.
DR   TreeFam; TF106503; -.
DR   PathwayCommons; O15504; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; O15504; -.
DR   SIGNOR; O15504; -.
DR   BioGRID-ORCS; 11097; 70 hits in 1159 CRISPR screens.
DR   ChiTaRS; NUPL2; human.
DR   GeneWiki; NUPL2; -.
DR   GenomeRNAi; 11097; -.
DR   Pharos; O15504; Tbio.
DR   PRO; PR:O15504; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; O15504; protein.
DR   Bgee; ENSG00000136243; Expressed in cerebellar hemisphere and 186 other tissues.
DR   ExpressionAtlas; O15504; baseline and differential.
DR   Genevisible; O15504; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005635; C:nuclear envelope; IDA:ComplexPortal.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005643; C:nuclear pore; NAS:ComplexPortal.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005049; F:nuclear export signal receptor activity; IDA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; NAS:ComplexPortal.
DR   GO; GO:0006611; P:protein export from nucleus; IGI:GO_Central.
DR   InterPro; IPR000571; Znf_CCCH.
DR   PANTHER; PTHR46527:SF1; NUCLEOPORIN NUP42; 1.
DR   PANTHER; PTHR46527; NUCLEOPORIN-LIKE PROTEIN 2; 1.
DR   SMART; SM00356; ZnF_C3H1; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Glycoprotein; Membrane; Metal-binding;
KW   mRNA transport; Nuclear pore complex; Nucleus; Phosphoprotein;
KW   Protein transport; Reference proteome; Repeat; Translocation; Transport;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..423
FT                   /note="Nucleoporin NUP42"
FT                   /id="PRO_0000204895"
FT   REPEAT          14..15
FT                   /note="FG 1"
FT   REPEAT          95..96
FT                   /note="FG 2"
FT   REPEAT          218..219
FT                   /note="FG 3"
FT   REPEAT          220..221
FT                   /note="FG 4"
FT   REPEAT          265..266
FT                   /note="FG 5"
FT   REPEAT          271..272
FT                   /note="FG 6"
FT   REPEAT          288..289
FT                   /note="FG 7"
FT   REPEAT          290..291
FT                   /note="FG 8"
FT   REPEAT          311..312
FT                   /note="FG 9"
FT   REPEAT          336..337
FT                   /note="FG 10"
FT   REPEAT          345..346
FT                   /note="FG 11"
FT   REPEAT          364..365
FT                   /note="FG 12"
FT   ZN_FING         1..25
FT                   /note="C3H1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          24..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..170
FT                   /note="Interaction with HIV-1 Vpr"
FT   REGION          365..423
FT                   /note="Interaction with GLE1"
FT                   /evidence="ECO:0000269|PubMed:16000379"
FT   COMPBIAS        31..71
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..228
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016480"
FT   VAR_SEQ         204..224
FT                   /note="LSDVKDGVNQAAPAFGFGSSQ -> KCLWKIYTHLSPKIYGPDCAL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_016481"
FT   VAR_SEQ         225..423
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_016482"
FT   VARIANT         391
FT                   /note="D -> N (in dbSNP:rs13243961)"
FT                   /id="VAR_050572"
FT   VARIANT         392
FT                   /note="K -> N (in dbSNP:rs34902971)"
FT                   /id="VAR_050573"
FT   HELIX           395..402
FT                   /evidence="ECO:0007829|PDB:6B4F"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:6B4F"
FT   HELIX           418..420
FT                   /evidence="ECO:0007829|PDB:6B4F"
SQ   SEQUENCE   423 AA;  44872 MW;  6F8B95073312E999 CRC64;
     MAICQFFLQG RCRFGDRCWN EHPGARGAGG GRQQPQQQPS GNNRRGWNTT SQRYSNVIQP
     SSFSKSTPWG GSRDQEKPYF SSFDSGASTN RKEGFGLSEN PFASLSPDEQ KDEKKLLEGI
     VKDMEVWESS GQWMFSVYSP VKKKPNISGF TDISPEELRL EYHNFLTSNN LQSYLNSVQR
     LINQWRNRVN ELKSLNISTK VALLSDVKDG VNQAAPAFGF GSSQAATFMS PGFPVNNSSS
     DNAQNFSFKT NSGFAAASSG SPAGFGSSPA FGAAASTSSG ISTSAPAFGF GKPEVTSAAS
     FSFKSPAASS FGSPGFSGLP ASLATGPVRA PVAPAFGGGS SVAGFGSPGS HSHTAFSKPS
     SDTFGNSSIS TSLSASSSII ATDNVLFTPR DKLTVEELEQ FQSKKFTLGK IPLKPPPLEL
     LNV
//
